Pharmacological profile of the atypical neuroleptic sertindole.

In vivo cardiovascular effects of the new atypical neuroleptic sertindole.

Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.

Sertindole: cardiac electrophysiological profile.

Sertindole: safety and tolerability profile.

Sertindole: a clinical efficacy profile.

Sertindole, a new neuroleptic with extreme selectivity on A10 versus A9 dopamine neurones in the rat.

Malignant neuroleptic syndrome: an atypical case.

An atypical case of neuroleptic malignant syndrome precipitated by valproate.

Atypical Neuroleptic Malignant Syndrome Associated with Use of Clozapine.

Bromerguride--an ergoline derivative with atypical neuroleptic properties.

Clobazam: pharmacological and therapeutic profile.

Post-marketing surveillance of sertindole.

Electrocardiographic profile of adenosine pharmacological stress testing.

Phytochemical and pharmacological profile of Ipomoea aquatica.

[Pharmacological and clinical profile of afatinib (Giotrif®)].

Pharmacological profile of a native dermatan sulfate.

Pharmacological profile of novel psychoactive benzofurans.

The ethnobotanical, phytochemical and pharmacological profile of the genus Pinellia.

Pharmacological profile of the aerial parts of Rubus ulmifolius Schott.

The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine.

Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association.

Aripiprazole: from pharmacological profile to clinical use.

Antidepressants: pharmacological profile and clinical consequences.

QT dynamics during treatment with sertindole.

Suggest Documents

In vivo cardiovascular effects of the new atypical neuroleptic sertindole.

Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.

Sertindole: cardiac electrophysiological profile.

Sertindole: safety and tolerability profile.

Sertindole: a clinical efficacy profile.

Sertindole, a new neuroleptic with extreme selectivity on A10 versus A9 dopamine neurones in the rat.

Malignant neuroleptic syndrome: an atypical case.

An atypical case of neuroleptic malignant syndrome precipitated by valproate.

Atypical Neuroleptic Malignant Syndrome Associated with Use of Clozapine.

Bromerguride--an ergoline derivative with atypical neuroleptic properties.

Clobazam: pharmacological and therapeutic profile.

Post-marketing surveillance of sertindole.

Electrocardiographic profile of adenosine pharmacological stress testing.

Phytochemical and pharmacological profile of Ipomoea aquatica.

[Pharmacological and clinical profile of afatinib (Giotrif®)].

Pharmacological profile of a native dermatan sulfate.

Pharmacological profile of novel psychoactive benzofurans.

The ethnobotanical, phytochemical and pharmacological profile of the genus Pinellia.

Pharmacological profile of the aerial parts of Rubus ulmifolius Schott.

The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine.

Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association.

Aripiprazole: from pharmacological profile to clinical use.

Antidepressants: pharmacological profile and clinical consequences.

QT dynamics during treatment with sertindole.

Pharmacological profile of the atypical neuroleptic sertindole.

Recommend Documents

Follow Us